Skip to Main Content


Over the Counter Products: Is Implied Preemption a Viable Defense?

September 2017 - DRI's For The Defense
Social Logo Social Logo Social Logo

by Richard Dean, K. Michele Anderson, and Corena Larimer, published in DRI's For The Defense

Courts have issued many preemption decisions involving brand-name and generic drugs in recent years, but only a handful involved over-the-counter (OTC) products. Preemption of claims involving OTC products is a complicated area generally, made much more so by the different regulatory avenues to market and numerous detailed regulations specific to particular drug substances or categories of drugs. This article provides an overview of implied preemption in the world of OTC products.

Read the article here.

Related Attorneys

Related Article

Corn, Justice Brandeis, Litigation Tourism and Dormant Commerce Clause Revisited More
lingua negoti
The language of business.
Perspectives on employee benefits, executive compensation and ERISA litigation to help you attract and retain talent.
Ohio Environmental
Insights and commentary for the business and legal community.